Bio-Rad Laboratories (BIO) Return on Assets (ROA)
Market Cap: $7.01B
Avg Volume: 356.48K
Industry: Medical - Devices
Sector: Healthcare
Bio-Rad Laboratories Return on Assets (ROA) Summary
Bio-Rad Laboratories's ROA indicates the return generated on the company's assets:
- Annual: -19.69%
- Quarterly: -7.64%
- TTM: -19.69%
What is Return on Assets (ROA)?
Return on Assets (ROA) is a financial ratio that shows the percentage of profit a company earns in relation to its overall resources. It is an indicator of how efficiently a company is using its assets to generate earnings.
Related Metrics
Other important metrics to assess Bio-Rad Laboratories's profitability include:
- ROE (Return on Equity) - measures the return generated on shareholders' equity:
- Annual: -28.07%
- Quarterly: -10.90%
- TTM: -24.68%
- ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
- Annual: 3.29%
- Quarterly: 0.51%
- TTM: 2.42%
- Return on Tangible Assets - measures the return generated on the company's tangible assets:
- Annual: -21.30%
- Quarterly: -8.27%
- TTM: -21.30%
- Profit Margin - shows the percentage of revenue that has turned into profit:
- Annual: -71.86%
- Quarterly: -107.24%
- TTM: -71.86%
These metrics provide insights into Bio-Rad Laboratories's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual ROA
-19.69%
Quarterly ROA
-7.64%
TTM ROA
-19.69%
Bio-Rad Laboratories Historical ROA
Historical ROE
Historical ROIC
Historical Profit Margin
Historical Return on Tangible Assets
Bio-Rad Laboratories Historical Profitability Metrics
The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | ROA | ROE | ROIC | Profit Margin | Return on Tangible Assets |
|---|---|---|---|---|---|
| 2024 | -19.69% | -28.07% | 3.29% | -71.86% | -21.30% |
| 2023 | -5.18% | -7.29% | 2.14% | -23.86% | -5.51% |
| 2022 | -26.87% | -37.73% | 2.87% | -129.45% | -28.42% |
| 2021 | 23.93% | 31.13% | 2.23% | 145.57% | 24.77% |
| 2020 | 29.40% | 38.61% | 2.57% | 149.83% | 30.56% |
| 2019 | 21.96% | 30.56% | 2.36% | 76.08% | 23.14% |
| 2018 | 6.44% | 8.99% | -1.50% | 15.76% | 6.86% |
| 2017 | 2.69% | 3.92% | 3.63% | 5.31% | 3.19% |
| 2016 | 0.73% | 1.09% | 1.07% | 1.36% | 0.88% |
| 2015 | 3.05% | 4.54% | 4.11% | 5.60% | 3.77% |
Related Metrics
Explore detailed financial metrics and analysis for BIO.